Singapore, March 24 -- Co-Diagnostics, Inc. has signed an agreement for CoSara Diagnostics, the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises (ASE Group), to significantly expand its commercial and distribution territory across South Asia to now include Bangladesh, Pakistan, Nepal, and Sri Lanka.

The expansion significantly increases CoSara's addressable market across South Asia, bringing the total regional opportunity to an estimated $13 billion based on internal analyses and third-party market data. It also supports CoSara's plans to commercialise the CoSara PCR Pro(R) point-of-care instrument and tests as well as the SARAGENE(R) product line across the region, subject to applicable regulatory approvals in each ju...